credibility, page-13

Credibility and credentials go to the core of the problem with Alchemia and many other Aussie Biotechs.

Understandably the funding question and continued discussion to and fro is creating a great deal of angst.

I think most holders are here for the science and so the success/potential of the company needs to be weighed up against the current (and post Trading Halt) SP.

The CEO is understandably under barrage and focusing his talk to the market on cashflow, but he should also be selling the "sizzle".

A common thread amongst many CEO's/Directors of Aussie Biotechs is their inability to be able to sell their companies on the fundamentals. Most are Scientists first and Business people second (or third).

If you listen to CEO of AusBiotech, Dr Anna Lavelle's recent state of the industry interview that was referenced on this forum a few days ago (http://www.pwc.com.au/industry/technology/biotechnology-update/index.htm), she focused on the need for CEOs to not just sit back and let the science do the talking, but to get out there and sell the sizzle.

In the case of Alchemia, their science is almost selling itself, so the company only needs to do a little more to help it along. For example, just over one month ago, one of the Phase II HA-Irinotecan researchers came out with some great info after 2 patients showed dramatic improvements after only 10 days treatment. Although this was only 5 weeks ago, the results were so dramatic, it might be worth another update on these patents and/or others - assuming the news is still good.

The fundamentals of this company in terms of its science are still without question and are probably the reason most holders are still here - its time for management to get out there and peddle their wares on the opportunity that exists.

The Scientists (and the Directors) who run most of the Aussie Biotechs are perhaps not up to the job of running these companies from a business perspective. Perhaps its time for shareholders to be pushing Biotechs into a rethink about the type of people required to run these companies - I'd rather a business person with Public Company performance runs on the board and not necessarily the obligatory scientific credentials.